EP2095804A2 - Medical device for healing and preventing decubitus ulcers - Google Patents
Medical device for healing and preventing decubitus ulcers Download PDFInfo
- Publication number
- EP2095804A2 EP2095804A2 EP09153693A EP09153693A EP2095804A2 EP 2095804 A2 EP2095804 A2 EP 2095804A2 EP 09153693 A EP09153693 A EP 09153693A EP 09153693 A EP09153693 A EP 09153693A EP 2095804 A2 EP2095804 A2 EP 2095804A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- cavities
- patient
- oxygen
- sores
- module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000004210 Pressure Ulcer Diseases 0.000 title claims abstract description 21
- 230000035876 healing Effects 0.000 title claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 12
- 238000005273 aeration Methods 0.000 claims abstract description 6
- 210000003141 lower extremity Anatomy 0.000 claims abstract 2
- 210000000954 sacrococcygeal region Anatomy 0.000 claims abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 26
- 229910052760 oxygen Inorganic materials 0.000 claims description 26
- 239000001301 oxygen Substances 0.000 claims description 26
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 125000006850 spacer group Chemical group 0.000 claims description 5
- 238000002640 oxygen therapy Methods 0.000 claims description 4
- 244000052616 bacterial pathogen Species 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 210000003423 ankle Anatomy 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 238000009792 diffusion process Methods 0.000 claims description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical class [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 238000007906 compression Methods 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000007954 hypoxia Effects 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 206010011985 Decubitus ulcer Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010061728 Bone lesion Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001095 motoneuron effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002221 olecranon process Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
- A61G7/05—Parts, details or accessories of beds
- A61G7/057—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
- A61G7/05—Parts, details or accessories of beds
- A61G7/057—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
- A61G7/05784—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with ventilating means, e.g. mattress or cushion with ventilating holes or ventilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
- A61G7/002—Beds specially adapted for nursing; Devices for lifting patients or disabled persons having adjustable mattress frame
- A61G7/015—Beds specially adapted for nursing; Devices for lifting patients or disabled persons having adjustable mattress frame divided into different adjustable sections, e.g. for Gatch position
Definitions
- the bed is the element with which the hospitalized patient is in closest contact in the hospital environment.
- decubitus ulcer or “pressure sore” resulting from confinement to bed is meant a tissue lesion presenting a necrotic evolution that involves the cutis, the derma, and the subcutaneous layers, until, in more serious cases, the muscle, the cartilage and even the bone are affected.
- the phenomenon is caused by a prolonged and/or excessive pressure exerted between the resting surface and the surface of the bone, such as to cause a mechanical stress on the tissues and an alteration of the local blood circulation.
- the lesions are noted in sites that are particularly predisposed, such as the bone prominences (sacrum, heel, olecranon, trochanter) and arise as a result of prolonged confinement to bed in an obligate position. Consequently, they tend to form prevalently in subjects affected by pathological conditions that jeopardize their neuromotor functionality and, in elderly bedridden subjects, above all if they are affected by systemic diseases, such as diabetes mellitus, renal insufficiency, immunodepression, circulatory disorders, etc., which constitute a further aggravating circumstance.
- the principal physiopathological mechanisms that determine onset of decubitus ulcers are pressure and shear. Other conditions that perform a concomitant role are rubbing and moisture.
- the pressure exerted on the tissues is considered the principal pathogenic factor.
- the normal pressure in the arterial capillary circulation is 32 mmHg.
- the external compression becomes harmful for the tissues when it exceeds the critical level of 32 mmHg, since it leads to a reduction in the arrival of blood, with consequent ischaemia and hypoxia.
- the effects of compression vary not only according to the intensity and duration of the compression but also according to the site, the thickness of the cutis and of the soft tissue. It has been demonstrated, for example, that a pressure of 60-70 mmHg sustained for two hours may be sufficient to produce an irreversible injury.
- the cutaneous tissue is able to respond to the insult caused by the compression with a compensatory hyperaemia, in elderly patients this is generally insufficient to protect it from the risk of hypoxia.
- the cells In the absence of oxygen, the cells use an anaerobic metabolism, which produces toxic substances and local acidosis, increase of vasal permeability, formation of transudate and oedema, as well as further cellular suffering, up to necrosis.
- Shear forces determine a progressive mutual displacement of surfaces constituted by elements set on top of one another.
- Said forces occur, for example, either when the bed head is raised, with the tendency of the trunk of the body to slide down and the segments of the body of the patient to slip from one position to another.
- a pulling action is exerted on the soft surface tissues anchored by the deep muscular fasciae, with the effect of stretching, possible angulation, microthromboses, obstruction and recision of the small vessels, hypoxia, and consequent deep-tissue necrosis.
- Rubbing determines removal of the more superficial layer of the skin, the corneal layer, with consequent reduction of the fibrinolytic activity of the derma, rendering the latter more susceptible to necrosis resulting from compression.
- a prolonged exposure of the cutis to moisture causes phenomena of maceration and alteration of the pH, thus reducing the barrier function performed by the cutis itself.
- a first purpose of the present invention is to provide an innovative mattress that is able to prevent formation of decubitus ulcers.
- a second purpose of the invention is to heal said ulcers in the case where they have formed.
- a medical device comprising a modular mattress provided with means for forced aeration of the areas of the body presenting sores or subject to developing sores.
- the invention is substantially constituted by a modular and adjustable mattress, which is provided with means for forced aeration of the areas of the body more subject to formation of decubitus ulcers, such as, for instance, the sacral area and the area of patient's heels, which is made of a particularly soft spongy material and envisages cavities in areas corresponding to parts of the body that are subject to risks of developing decubitus ulcers.
- the mattress may be made of a single piece, the preferred embodiment described herein is made up of at least three parts or modules: a top module A, a central module B, and a bottom module C.
- the top module A is designed to provide a support for the head and the shoulders of the bedridden patient.
- the central module B is provided with a hole or cavity FS in an area corresponding to the sacral area, whilst the bottom module C is provided with two holes or cavities FT in an area corresponding to the patient's heels.
- the distance between the head and the sacral cavity FS and the distance between this and the cavities provided for the heels FT can be adjusted, according to the structure of the patient's body, by interposing between the modules A, B, C so far described, the purposely designed spacers D. In this way, it is advantageously possible to adapt the mattress to the body of the patient.
- the inventive idea underlying the present invention substantially consists in guaranteeing a forced aeration to the areas of the body that are susceptible to developing decubitus ulcers.
- the sacral cavity FS and the cavities for the patient's heels FT are provided with at least one inlet duct from which oxygen arrives and at least one outlet duct from which the oxygenated air leaving the area presenting sores exits to guarantee a continuous change therein.
- the cavities in an area corresponding to the ulcers form, around each of them, a sort of "fluid-tight chamber", which is defined laterally by the walls of the cavities, at the top by the surface of the body of the patient, and at the bottom by the surface on which the mattress rests.
- the sacral cavity FS has a duct 11 for inlet of the oxygen and five outlet ducts 1, 2, 11, 12, 13 arranged substantially in radial fashion.
- each of the cavities FT corresponding to the patient's heels has a duct 12 for inlet of the oxygen and four outlet ducts 3, 4, 5, 6 and 7, 8, 9, 10, respectively, arranged substantially in radial fashion.
- Said inlet/outlet ducts, embedded in the thickness of the mattress, are preferably made of hard plastic material so as not to undergo any deformation with the weight of the patient, thus guaranteeing proper inflow/outflow of the oxygen into/from the cavity and hence into/from the area to be treated.
- the presence of the cavities for the sacral area and for the patient's heels advantageously prevents their formation, whilst, in the case where the epidermis of the patient is affected by decubitus ulcers, it is obtained that the transcutaneous increase in the concentration of oxygen stimulates growth of new cells, with particular reference to fibroplasts, essential for the synthesis of collagenase, as well as of new blood vessels, which prove insufficient at the level of the necrotic areas of the lesions, thus increasing release of endogenous oxygen.
- tissue repair will proceed faster and above all will be more effective, in particular ensuring safety of the system since it should be emphasized that, with low-pressure topical oxygen therapy, there is no systemic absorption and hence no risk for the cardio-pulmonary and nervous systems.
- oxygen performs a bactericidal role for anaerobic germs such as Staphylococcus aureus and E. coli.
- a small sac or bag CL for the collection of the colliquation material of the sores, appropriately provided in each of the cavities FC and FT.
- the sac is preferably impermeable to liquids and permeable to gas to allow the oxygen to pass.
- the walls of the holes or cavities have a certain stiffness to guarantee the presence of a minimum volume for application of oxygen therapy to the ulcers. From the experiments conducted, it has been possible to note that the minimum volume of said sacral cavity FS and heel cavities FT is preferably 2512 cm 3 .
- the number and dimensions of the spacers D can be modified according to the requirements.
- the moisture in the critical areas is substantially eliminated thanks to the presence of the aforesaid holes or cavities and is reduced in the remaining areas thanks to the transpirant capacity of the spongy material of which the mattress is made.
- the oxygen is preferably taken from the hospital supply system and, from what has been said, is applied directly on the "exposed" ulcer, which has been previously cleaned with physiological solution.
- the oxygen therapy just referred to presents different therapeutic indications, amongst which:
- Adoption of the mattress according to the present invention envisages use of oxygen, which must be appropriately humidified and delivered at a controlled temperature using means of a known type.
- the oxygen can also be supplied from a normal oxygen cylinder provided with means known for regulating the pressure, temperature, and humidity.
- the treatment of decubitus ulcers according to the invention varies according to the type of the sore in question, the site, and the metabolic and psychosomatic conditions of the patient.
- a covering sheet that covers the three modules and the possible spacers set between them, which is made of material impermeable to liquids and transpirant for gases, bacteriostatic, and easy to clean.
- Said covering sheet is provided with a bi-elastic cover that is transpirant and liquid-repellent, which can be readily removed for washing thanks to a purposely provided zip, which is completely hidden to prevent infiltration of any sort into the mattress itself.
- said cover is provided with lateral holes to enable exit of the oxygen from the ducts extending from the sacral cavity FS and/or the cavities corresponding to the patient's heels FT.
- a possible variant may regard the position and/or size and/or shape of the holes or cavities in positions corresponding to the ulcered areas.
Landscapes
- Health & Medical Sciences (AREA)
- Nursing (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Invalid Beds And Related Equipment (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
- The bed is the element with which the hospitalized patient is in closest contact in the hospital environment.
- It frequently occurs, especially in the cases of a prolonged stay in hospital with continuous confinement to bed, both in the acute phase of illness and in the subsequent phase, that decubitus ulcers form in areas of the body that are at greater risk of developing them, in particular, in the sacral part and in areas corresponding to the patient's heels.
- There currently exist on the market only air mattresses or water mattresses (full-flotation beds), which, however, function only as a palliative and substantially have the function of preventing formation of decubitus ulcers, but not that of healing them after they have developed.
- Consequently, the prevention and treatment of trophic sores resulting from confinement to bed represent, in the domestic and hospital context, an important problem of health care, which requires a considerable commitment in terms of human and economic resources, as well as of materials and technologies.
- By " decubitus ulcer" or "pressure sore" resulting from confinement to bed is meant a tissue lesion presenting a necrotic evolution that involves the cutis, the derma, and the subcutaneous layers, until, in more serious cases, the muscle, the cartilage and even the bone are affected.
- The phenomenon is caused by a prolonged and/or excessive pressure exerted between the resting surface and the surface of the bone, such as to cause a mechanical stress on the tissues and an alteration of the local blood circulation. Clinically, the lesions are noted in sites that are particularly predisposed, such as the bone prominences (sacrum, heel, olecranon, trochanter) and arise as a result of prolonged confinement to bed in an obligate position. Consequently, they tend to form prevalently in subjects affected by pathological conditions that jeopardize their neuromotor functionality and, in elderly bedridden subjects, above all if they are affected by systemic diseases, such as diabetes mellitus, renal insufficiency, immunodepression, circulatory disorders, etc., which constitute a further aggravating circumstance.
- The principal physiopathological mechanisms that determine onset of decubitus ulcers are pressure and shear. Other conditions that perform a concomitant role are rubbing and moisture.
- The pressure exerted on the tissues is considered the principal pathogenic factor.
- The normal pressure in the arterial capillary circulation is 32 mmHg.
- The external compression becomes harmful for the tissues when it exceeds the critical level of 32 mmHg, since it leads to a reduction in the arrival of blood, with consequent ischaemia and hypoxia.
- The effects of compression vary not only according to the intensity and duration of the compression but also according to the site, the thickness of the cutis and of the soft tissue. It has been demonstrated, for example, that a pressure of 60-70 mmHg sustained for two hours may be sufficient to produce an irreversible injury.
- If the cutaneous tissue is able to respond to the insult caused by the compression with a compensatory hyperaemia, in elderly patients this is generally insufficient to protect it from the risk of hypoxia.
- In the absence of oxygen, the cells use an anaerobic metabolism, which produces toxic substances and local acidosis, increase of vasal permeability, formation of transudate and oedema, as well as further cellular suffering, up to necrosis.
- Shear forces determine a progressive mutual displacement of surfaces constituted by elements set on top of one another.
- Said forces occur, for example, either when the bed head is raised, with the tendency of the trunk of the body to slide down and the segments of the body of the patient to slip from one position to another. In these cases, a pulling action is exerted on the soft surface tissues anchored by the deep muscular fasciae, with the effect of stretching, possible angulation, microthromboses, obstruction and recision of the small vessels, hypoxia, and consequent deep-tissue necrosis.
- Rubbing, albeit not presenting a major pathogenic role, determines removal of the more superficial layer of the skin, the corneal layer, with consequent reduction of the fibrinolytic activity of the derma, rendering the latter more susceptible to necrosis resulting from compression.
- Moisture intensifies the action of the other factors because it renders the skin more brittle and more subject to assault. A prolonged exposure of the cutis to moisture causes phenomena of maceration and alteration of the pH, thus reducing the barrier function performed by the cutis itself.
- A first purpose of the present invention is to provide an innovative mattress that is able to prevent formation of decubitus ulcers.
- A second purpose of the invention is to heal said ulcers in the case where they have formed.
- This has been obtained, according to the invention, by providing a medical device comprising a modular mattress provided with means for forced aeration of the areas of the body presenting sores or subject to developing sores.
- A better understanding of the invention will be obtained from the ensuing detailed description with reference to the attached figures, which illustrate, purely by way of non-limiting example, a preferred embodiment thereof.
- In the drawings:
-
Figure 1 is a top plan view of the invention, which shows the principal parts of the mattress; -
Figure 2 is a 3D view that shows further details of the invention, in which the ducts for the oxygen are further highlighted; -
Figure 3 , which is similar to the previous one, shows the case where a spacing element is positioned between the sacral area and the legs of the user; -
Figure 4 , which is similar to the previous one, shows different spacer sizes; -
Figures 5 and 6 are 3D views that show the invention with removable cover; -
Figure 7 represents activated-carbon filters for elimination of odours; -
Figures 8 and 9 show the size of the cavities and of the means for collection of the colliquation material of the decubitus ulcers; -
Figures 10 and 11 are a perspective view and plan view, respectively, of the means for resting of the patient's feet on the respective anti-ulcer cavities; and -
Figures 12-14 show the sequence of installation of said means for resting of the patient's feet in their own site. - In the light of the physiopathological mechanisms referred to above that determine onset of the decubitus ulcers, the invention is substantially constituted by a modular and adjustable mattress, which is provided with means for forced aeration of the areas of the body more subject to formation of decubitus ulcers, such as, for instance, the sacral area and the area of patient's heels, which is made of a particularly soft spongy material and envisages cavities in areas corresponding to parts of the body that are subject to risks of developing decubitus ulcers.
- Even though the mattress may be made of a single piece, the preferred embodiment described herein is made up of at least three parts or modules: a top module A, a central module B, and a bottom module C.
- The top module A is designed to provide a support for the head and the shoulders of the bedridden patient.
- According to the invention, the central module B is provided with a hole or cavity FS in an area corresponding to the sacral area, whilst the bottom module C is provided with two holes or cavities FT in an area corresponding to the patient's heels.
- The distance between the head and the sacral cavity FS and the distance between this and the cavities provided for the heels FT can be adjusted, according to the structure of the patient's body, by interposing between the modules A, B, C so far described, the purposely designed spacers D. In this way, it is advantageously possible to adapt the mattress to the body of the patient.
- As has already been mentioned previously, the inventive idea underlying the present invention substantially consists in guaranteeing a forced aeration to the areas of the body that are susceptible to developing decubitus ulcers. For this purpose, according to the invention, the sacral cavity FS and the cavities for the patient's heels FT are provided with at least one inlet duct from which oxygen arrives and at least one outlet duct from which the oxygenated air leaving the area presenting sores exits to guarantee a continuous change therein.
- It should in fact be noted that, with the configuration just described, the cavities in an area corresponding to the ulcers form, around each of them, a sort of "fluid-tight chamber", which is defined laterally by the walls of the cavities, at the top by the surface of the body of the patient, and at the bottom by the surface on which the mattress rests.
- Basically, within each of the "fluid-tight chambers" that are positioned in an area corresponding to the sores, there is prevalently an atmosphere with a high concentration of oxygen, which is higher than 80% and preferably equal to approximately 99.9%, that is delivered with the following characteristics:
- pressure: 1.03 bar
- temperature: 21±2°C
- humidity: 40-70%
- In the example of embodiment described, the sacral cavity FS has a
duct 11 for inlet of the oxygen and five 1, 2, 11, 12, 13 arranged substantially in radial fashion.outlet ducts - Likewise, each of the cavities FT corresponding to the patient's heels has a
duct 12 for inlet of the oxygen and four outlet ducts 3, 4, 5, 6 and 7, 8, 9, 10, respectively, arranged substantially in radial fashion. - Evidently, both the number and arrangement of the inlet/outlet ducts can be varied.
- Said inlet/outlet ducts, embedded in the thickness of the mattress, are preferably made of hard plastic material so as not to undergo any deformation with the weight of the patient, thus guaranteeing proper inflow/outflow of the oxygen into/from the cavity and hence into/from the area to be treated.
- According to the present invention, in the case where the sores are not present, the presence of the cavities for the sacral area and for the patient's heels advantageously prevents their formation, whilst, in the case where the epidermis of the patient is affected by decubitus ulcers, it is obtained that the transcutaneous increase in the concentration of oxygen stimulates growth of new cells, with particular reference to fibroplasts, essential for the synthesis of collagenase, as well as of new blood vessels, which prove insufficient at the level of the necrotic areas of the lesions, thus increasing release of endogenous oxygen.
- In this way, tissue repair will proceed faster and above all will be more effective, in particular ensuring safety of the system since it should be emphasized that, with low-pressure topical oxygen therapy, there is no systemic absorption and hence no risk for the cardio-pulmonary and nervous systems.
- Finally, it should be noted that oxygen performs a bactericidal role for anaerobic germs such as Staphylococcus aureus and E. coli.
- Given that the oxygen that irrigates the necrotic and ulcered areas exits from the mattress and is dispersed in the patient's room, it is evident that this causes diffusion of unwholesome odours and the possible propagation of germs into the environment itself.
- For this purpose, it is preferable to provide, in the terminal stretch of each outlet duct from the sacral cavity or from the cavity corresponding to the patient's heels, an activated-carbon filter FC of a known type.
- Furthermore, the presence of a slight rise R at the level of the cervical dorsal stretch in the top module A and the presence of supports for the ankles in the bottom module C, together with the sacral holes or cavities FS and heel holes or cavities FT, reduce the shear forces and rubbing of the skin over the entire surface of the body.
- For hygienic reasons, it is preferable to envisage also a small sac or bag CL for the collection of the colliquation material of the sores, appropriately provided in each of the cavities FC and FT. The sac is preferably impermeable to liquids and permeable to gas to allow the oxygen to pass.
- The walls of the holes or cavities have a certain stiffness to guarantee the presence of a minimum volume for application of oxygen therapy to the ulcers. From the experiments conducted, it has been possible to note that the minimum volume of said sacral cavity FS and heel cavities FT is preferably 2512 cm3.
- The number and dimensions of the spacers D can be modified according to the requirements.
- Finally, it should be noted that the moisture in the critical areas is substantially eliminated thanks to the presence of the aforesaid holes or cavities and is reduced in the remaining areas thanks to the transpirant capacity of the spongy material of which the mattress is made.
- The oxygen is preferably taken from the hospital supply system and, from what has been said, is applied directly on the "exposed" ulcer, which has been previously cleaned with physiological solution.
- The oxygen therapy just referred to presents different therapeutic indications, amongst which:
- phlebostatic sores and ulcers;
- sores and discontinuities of the skin in arteriopathic patients;
- wounds infected with mixed flora;
- sores or wounds or ulcers in diabetic patients;
- tissue lesions in patients undergoing cortisone therapy, as in the case of rheumatoid arthritis or the like;
- infected and exposed bone lesions;
- skin transplants subject to risk owing to local or general conditions;
- burns that are infected or susceptible to risk of infection.
- From the experiments conducted, the use of the invention has yielded excellent results in the cases of patients affected by decubitus ulcers of different degree and deriving from a wide range of pathological conditions. In all the cases treated, there has been obtained: cleaning of the lesion, reduction of the diameters, clear evidence of tissue granulation already starting from the third day of application, and above all a reduction in the time required for healing corresponding to a saving of 35%-40%.
- Adoption of the mattress according to the present invention envisages use of oxygen, which must be appropriately humidified and delivered at a controlled temperature using means of a known type.
- The oxygen can also be supplied from a normal oxygen cylinder provided with means known for regulating the pressure, temperature, and humidity.
- The treatment of decubitus ulcers according to the invention varies according to the type of the sore in question, the site, and the metabolic and psychosomatic conditions of the patient.
- In general, there is in any case recommended daily use thereof for approximately 4-5 hours up to complete healing.
- There are no contraindications to the simultaneous use of hydrocolloids and antibioted medicaments. Counter-indicated, instead, is manual curettage on account of the high deobstruent and infective power that it can cause, contrary to the philosophy of the treatment described herein.
- Finally, it is preferable to provide a covering sheet that covers the three modules and the possible spacers set between them, which is made of material impermeable to liquids and transpirant for gases, bacteriostatic, and easy to clean. Said covering sheet is provided with a bi-elastic cover that is transpirant and liquid-repellent, which can be readily removed for washing thanks to a purposely provided zip, which is completely hidden to prevent infiltration of any sort into the mattress itself.
- Evidently, said cover is provided with lateral holes to enable exit of the oxygen from the ducts extending from the sacral cavity FS and/or the cavities corresponding to the patient's heels FT.
- The present invention has been described and illustrated in a preferred embodiment thereof, but it is clear that a person skilled in the branch may make technically and/or functionally equivalent modifications and/or replacements thereto, without thereby departing from the sphere of protection of the present industrial patent right.
- For instance, a possible variant may regard the position and/or size and/or shape of the holes or cavities in positions corresponding to the ulcered areas.
Claims (18)
- A medical device for healing and/or preventing decubitus ulcers, characterized in that it is provided with means for forced aeration of the areas of the body affected by sores or subject to developing sores and substantially comprises a modular and adjustable mattress, which is made of a particularly soft spongy material and envisages cavities in areas of the body that present risks of developing decubitus ulcers.
- The device according to the preceding claim, characterized in that the mattress is made up of at least three parts or modules: a top module (A), a central module (B), and a bottom module (C).
- The device according to the preceding claim, characterized in that the top module (A) is designed to provide a support for the head and the shoulders of the bedridden patient, the central module (B) is designed to provide a support for the central area of the body, and the bottom module (C) is designed to provide a support for the lower limbs.
- The device according to Claim 2, characterized in that the central module (B) is provided with a hole or cavity (FS) in an area corresponding to the sacral region, whilst the bottom module (C) is provided with two holes or cavities (FT) in the area corresponding to the patient's heels.
- The device according to the preceding claim, characterized in that the distance between the head and the sacral cavity (FS) and the distance between this and the cavities for the heels (FT) are adjustable, according to the corporeal structure of the patient, by interposing between the top module (A) and the central module (B) and/or between the latter and the bottom module (C) one or more purposely provided transverse spacers (D); there thus being obtained the possibility of adapting the length of the mattress to the body of the patient.
- The device according to Claim 4 or Claim 5, characterized in that said means for forced aeration of the areas of the body subject to developing decubitus ulcers envisage that the hole or sacral cavity (FS) and the holes or cavities for the patient's heels (FT) are respectively provided with at least one inlet duct (11, 12), from which oxygen arrives, and at least one outlet duct (1-2, 11-13 and 3-10), from which there exits the oxygenated air that leaves the cavity in the area where decubitus ulcers are present in order to guarantee a continuous change therein.
- The device according to the preceding claim, characterized in that said oxygen supplied to the cavities in areas of the body presenting sores or presenting risk of developing sores is designed to guarantee within the cavities (FS, FT) an atmosphere with a concentration of oxygen equal to or higher than 80%, which is delivered with the following characteristics:- pressure: 1.03 bar- temperature: 21±2°C- humidity: 40-70%
- The device according to the preceding claim, characterized in that the concentration of oxygen in the cavities (FS, FT) in areas of the body affected by sores or presenting risk of developing sores is equal to approximately 99.9%.
- The device according to Claim 6, characterized in that the sacral cavity (FS) has an inlet duct (11) for the oxygen and five outlet ducts (1, 2, 11, 12, 13) arranged substantially in radial fashion.
- The device according to Claim 6, characterized in that each of the cavities in an area corresponding to the patient's heels (FT) has an inlet duct (12) for the oxygen and four outlet ducts (3-6 and 7-10) arranged substantially in radial fashion.
- The device according to Claim 6 or Claim 9 or Claim 10, characterized in that said inlet/outlet ducts, embedded in the thickness of the mattress, are made of hard plastic material so as not to undergo deformation with the weight of the patient's body, thus guaranteeing proper inflow/outflow of the oxygen into/from the cavity and hence into/from the area to be treated.
- The device according to Claim 6, characterized in that, in order to prevent diffusion of unwholesome odours and the possible propagation of germs in the patient's room, provided in the terminal stretch of each outlet duct (1-2, 11-13 and 3-10) coming from the sacral cavity (FS) and from the cavities for the patient's heels (FT) is an activated-carbon filter (FC) of a known type.
- The device according to Claim 3, characterized in that provided in the top module (A) is a slight rise (R) at the level of the dorsal cervical stretch, and provided in the bottom module (C) are supports for the ankles in such a way that, together with the sacral cavity (FS) and the cavities for the patient's heels (FT), the forces of shear and rubbing of the skin are reduced over the entire surface of the body.
- The device according to Claim 4, characterized in that provided in each of the cavities (FC and FT) is a small sac or bag (CL) for collection of the material of colliquation of the sores; the sac being impermeable to liquids and permeable to gas to allow the oxygen to pass through.
- The device according to Claim 4, characterized in that the side walls of the sacral cavity (FS) and heel cavities (FT) have a certain stiffness to guarantee the presence of a space of minimum volume available for application of oxygen therapy to the sores.
- The device according to the preceding claim, characterized in that said minimum volume of the cavities (FS, FT) is at least 2512 cm3.
- The device according to Claim 1, characterized in that the mattress is made of spongy material with high transpirant capacity.
- The device according to Claim 6 or Claim 7 or Claim 8, characterized in that the oxygen is drawn from the hospital oxygen-supply system or from a cylinder, and is appropriately humidified and brought to a temperature controlled with means of a known type.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000102A ITRM20080102A1 (en) | 2008-02-27 | 2008-02-27 | PRESIDIO MEDICO TO HEALTH AND PREVENT DECUBITUS PLEASURES EQUIPPED WITH MEANS OF FORCED VENTING OF INJURIES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2095804A2 true EP2095804A2 (en) | 2009-09-02 |
| EP2095804A3 EP2095804A3 (en) | 2010-03-10 |
Family
ID=40291927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09153693A Withdrawn EP2095804A3 (en) | 2008-02-27 | 2009-02-26 | Medical device for healing and preventing decubitus ulcers |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2095804A3 (en) |
| IT (1) | ITRM20080102A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700066027A1 (en) * | 2017-06-14 | 2018-12-14 | Fabio Panizza | ANTI-DECUBITUS MATTRESS OR CUSHION |
| CN109091342A (en) * | 2018-07-12 | 2018-12-28 | 天津医科大学第二医院 | A kind of operation of Bedsore prevention massage electric heating pad and its application method |
| CN114983699A (en) * | 2022-07-05 | 2022-09-02 | 江西卓瑞华医疗器械有限公司 | Bionic non-compression flexible laminating fixed-point stable type cardiovascular postoperative care equipment |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202200015633A1 (en) | 2022-10-28 | 2024-04-28 | Gian Carlo Manzitti | MEDICAL DEVICE FOR HEALING AND PREVENTING BEDSORES EQUIPPED WITH FORCED VENTILATION OF THE LESIONS WITH TREATMENT OF RESIDUES ARISING FROM OXYGENATION |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206524A (en) | 1978-10-10 | 1980-06-10 | Cook Roger G | Invalid supporting structure |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1636170A (en) * | 1970-06-12 | 1971-12-16 | Barber George | Improvements to beds particularly for sick or disabled persons |
| DE19505811C1 (en) * | 1995-02-08 | 1996-07-04 | Alfred Fischer | Foam mattress for patient with pelvic pressure ulcers |
-
2008
- 2008-02-27 IT IT000102A patent/ITRM20080102A1/en unknown
-
2009
- 2009-02-26 EP EP09153693A patent/EP2095804A3/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206524A (en) | 1978-10-10 | 1980-06-10 | Cook Roger G | Invalid supporting structure |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700066027A1 (en) * | 2017-06-14 | 2018-12-14 | Fabio Panizza | ANTI-DECUBITUS MATTRESS OR CUSHION |
| CN109091342A (en) * | 2018-07-12 | 2018-12-28 | 天津医科大学第二医院 | A kind of operation of Bedsore prevention massage electric heating pad and its application method |
| CN114983699A (en) * | 2022-07-05 | 2022-09-02 | 江西卓瑞华医疗器械有限公司 | Bionic non-compression flexible laminating fixed-point stable type cardiovascular postoperative care equipment |
| CN114983699B (en) * | 2022-07-05 | 2024-02-23 | 江西卓瑞华医疗器械有限公司 | Bionic compression-free, flexible, fixed-point and stable cardiovascular post-operative care equipment |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2095804A3 (en) | 2010-03-10 |
| ITRM20080102A1 (en) | 2009-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Quigley et al. | Skin integrity in the pediatric population: preventing and managing pressure ulcers | |
| US9839727B2 (en) | Negative pressure wound treatment device, and methods | |
| US20090260639A1 (en) | Prevention and Treatment of Pressure Sores Using Inflatable Devices | |
| AU2018231771A1 (en) | A wound dressing for combined negative pressure and fluid delivery system | |
| Dini et al. | Prevention and management of pressure ulcers | |
| IT201800005532A1 (en) | ANTI-DECUBITUS DEVICE, ANTI-DECUBITUS BED, METHOD OF MAKING AN ANTI-DECUBITUS MATTRESS | |
| EP2095804A2 (en) | Medical device for healing and preventing decubitus ulcers | |
| Peerless et al. | Skin complications in the intensive care unit | |
| Pertea et al. | Efficacy of negative pressure therapy (NPWT) in the management of wounds of different etiologies | |
| de Angelis et al. | Combined use of super‐oxidised solution with negative pressure for the treatment of pressure ulcers: case report | |
| Maklebust | Using wound care products to promote a healing environment | |
| Psoinos et al. | Use of gauze-based negative pressure wound therapy in a pediatric burn patient | |
| Guggisberg et al. | New perspectives in the treatment of decubitus ulcers | |
| US8939923B2 (en) | Oxygen healing system and method of use | |
| CN211634816U (en) | Spacing applying ointment or plaster to ECMO pipe is fixed | |
| US20240307210A1 (en) | Negative pressure therapy system with immobilizing locking sheets | |
| Miller et al. | APWCA Case# 3: Using Negative Pressure for Wound Therapy. | |
| US20260041588A1 (en) | Elevation Apparatus, System and Methods of Use | |
| Carville | Pressure Injury Prevention and Management in Palliative Care | |
| Dolinger | Pressure sores and optimum skin care | |
| Ratliff | Inflammation and Healing | |
| CN119654111A (en) | Lifting devices, systems and methods of use | |
| Kalyani et al. | A Patient Safety: Preventing Pressure Ulcers | |
| Cochrane | The severely disabled | |
| JP3118342U (en) | Comfort mat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| 17P | Request for examination filed |
Effective date: 20100528 |
|
| 17Q | First examination report despatched |
Effective date: 20101012 |
|
| AKY | No designation fees paid | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: 8566 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100911 |